(TBPH) Theravance Biopharma complete technical analysis [charts+indicators] | Buy/Sell Theravance Biopharma | (TBPH) share price targets
Complete technical analysis of Theravance Biopharma (TBPH) by charts plus indicators, forecast predictions and share price targets for Theravance Biopharma (TBPH)
Theravance Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-28 View latest technical analysis
10 day averaged volume of Theravance Biopharma is 186710
Date | Daily Closing Price | Open | High | Low | Volume |
28 Fri Mar 2025 | 9.23 | 9.33 | 9.42 | 9.18 | 0.724 times |
24 Mon Mar 2025 | 9.39 | 9.44 | 9.50 | 9.34 | 0.701 times |
21 Fri Mar 2025 | 9.39 | 9.32 | 9.55 | 9.32 | 1.436 times |
20 Thu Mar 2025 | 9.36 | 9.42 | 9.51 | 9.28 | 0.5 times |
19 Wed Mar 2025 | 9.47 | 9.22 | 9.50 | 9.19 | 0.537 times |
18 Tue Mar 2025 | 9.21 | 9.32 | 9.50 | 9.21 | 0.962 times |
17 Mon Mar 2025 | 9.35 | 9.24 | 9.44 | 9.24 | 0.896 times |
14 Fri Mar 2025 | 9.23 | 9.31 | 9.40 | 9.23 | 1.807 times |
13 Thu Mar 2025 | 9.28 | 9.39 | 9.39 | 9.06 | 0.988 times |
12 Wed Mar 2025 | 9.44 | 9.34 | 9.52 | 9.16 | 0.917 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 9.2 as stoploss in an intra day buy trade for a target of 9.35. However, stock will show a bearish move below 9.2.
Share price targets for Theravance Biopharma (TBPH)
Target Type | Value |
Downside Target | 8.14 |
Downside Target | 8.35 |
Downside Target | 8.78 |
Downside Target | 9.01 |
Upside Target | 9.70 |
Upside Target | 9.91 |
Upside Target | 10.19 |
Upside Target | 10.25 |
Upside Target | 10.26 |
Upside Target | 10.90 |
Intraday share price targets for Theravance Biopharma (TBPH)
Target Type | Value |
Downside Intraday Target | 9.11 |
Downside Intraday Target | 8.98 |
Upside Intraday Target | 9.43 |
Upside Intraday Target | 9.62 |
Upside Intraday Target | 9.3 |
Weekly technical analysis of Theravance Biopharma (TBPH)
Date | Weekly Closing Price | Open | High | Low | Volume |
28 Fri Mar 2025 | 9.23 | 9.44 | 9.50 | 9.18 | 0.329 times |
21 Fri Mar 2025 | 9.39 | 9.24 | 9.55 | 9.19 | 0.752 times |
14 Fri Mar 2025 | 9.23 | 9.47 | 9.70 | 9.06 | 0.781 times |
07 Fri Mar 2025 | 9.53 | 9.31 | 9.91 | 9.01 | 0.498 times |
28 Fri Feb 2025 | 9.35 | 9.30 | 10.19 | 8.78 | 3.187 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Theravance Biopharma (TBPH)
Date | Monthly Closing Price | Open | High | Low | Volume |
28 Fri Mar 2025 | 9.23 | 9.31 | 9.91 | 9.01 | 0.671 times |
28 Fri Feb 2025 | 9.35 | 9.25 | 10.19 | 8.78 | 1.193 times |
31 Fri Jan 2025 | 9.38 | 9.46 | 10.90 | 8.35 | 1.632 times |
31 Tue Dec 2024 | 9.41 | 9.89 | 10.25 | 9.34 | 0.621 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.32 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.32 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.